文献速递头颈外科

头颈癌患者功能结局问卷的开发

Development of a Patient-Centered Functional Outcomes Questionnaire in Head and Neck Cancer.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2020-01-01

该研究采用四阶段混合方法,在加拿大、美国、芬兰的三家头颈肿瘤中心开发并验证了Edmonton-33患者报告功能结局问卷。结果显示该问卷与吞咽、言语、口干、咀嚼等评估工具具有中至强相关性,各领域因子载荷均大于0.3,提示其可作为头颈癌患者功能结局的综合评估工具。

要点

  • Edmonton-33问卷与吞咽、言语、口干、咀嚼评估工具呈中至强相关。
  • 各领域因子载荷均大于0.3,吞咽和言语的均值分别为0.71和0.76。
  • 该问卷可用于头颈癌患者自我报告功能结局,作为单一综合测量工具。

核心结论

  • Edmonton-33问卷经验证可用于头颈癌患者评估和报告自身功能结局。

研究设计与样本

  • 四阶段混合方法定性研究,2013年7月1日至2016年6月30日在加拿大埃德蒙顿四級头颈肿瘤中心开展。
  • 患者来自三家头颈研究网络站点:阿尔伯塔大学、西奈山健康网络、图尔库大学医院。
  • 纳入标准为年龄≥18岁、头颈部鳞状细胞癌(口腔、口咽、下咽、喉)且治疗完成至少1年。
  • 排除正在接受额外积极治疗或证据显示疾病复发的患者。
  • 阶段1纳入10例患者(平均年龄59.6岁,男性6例占60%),阶段2纳入5例(平均年龄55.2岁),阶段3纳入10例,阶段4验证纳入25例(平均年龄62.6岁,男性14例占56%)。

主要发现

  • Edmonton-33评分与MD Anderson吞咽障碍量表吞咽评分强相关(r=0.77;95%CI,0.49-1.0)。
  • 与EORTC QLQ-H&N35吞咽评分强相关(r=-0.73;95%CI,-1.0至-0.44)。
  • 与改良钡餐吞咽试验强相关(r=-0.60;95%CI,-0.94至-0.25)。
  • 与言语障碍指数强相关(r=-0.64;95%CI,-0.97至-0.31),与单词可懂度(r=0.61;95%CI,0.27-0.95)和句子可懂度(r=0.55;95%CI,0.19-0.91)相关。
  • 与EORTC QLQ-H&N35口干领域(r=-0.54;95%CI,-0.91至-0.18)和咀嚼领域(r=-0.45;95%CI,-0.84至-0.06)呈中至强相关。

关键数值与推荐

  • 吞咽、言语、口干、咀嚼各领域因子载荷值均大于0.3。
  • 吞咽相关条目平均因子载荷0.71(95%CI,0.62-0.80),言语相关条目平均因子载荷0.76(95%CI,0.72-0.80)。
  • 口干相关条目平均因子载荷0.71(95%CI,0.59-0.83),咀嚼相关条目平均因子载荷0.77(95%CI,0.69-0.85)。

临床怎么用

  • Edmonton-33可作为头颈癌患者功能结局的单一综合评估工具,便于患者自我报告吞咽、言语、口干、咀嚼等功能。

局限性

  • 验证阶段样本量较小(25例),可能影响结果的外推性。
  • 研究仅在三个头颈肿瘤中心开展,人群代表性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Incorporation of patient perspectives, or patient-reported outcomes, in functional outcome measures has been gaining prominence in the literature on reconstructive surgery. OBJECTIVE: To create and validate an instrument for measuring the main functional areas of concern for patients with head and neck cancer. DESIGN, SETTING, AND PARTICIPANTS: This 4-phase mixed-methods qualitative study was conducted from July 1, 2013, to June 30, 2016, in a quaternary head and neck oncology center in Edmonton, Alberta, Canada. Patients were recruited from 3 Head and Neck Research Network sites: University of Alberta (Edmonton, Canada), Mount Sinai Health Network (New York, New York), and University of Turku Hospital (Turku, Finland). The inclusion criteria included 18 years of age or older, diagnosis of squamous cell carcinoma involving the subsites of the head and neck (ie, oral cavity, oropharynx, hypopharynx, and larynx), and at least 1 year since treatment completion. Those patients who were undergoing additional active treatment or with evidence of disease recurrence were excluded. Data were analyzed from July 1, 2013, to June 30, 2016. MAIN OUTCOMES AND MEASURES: The primary outcome measures were the clinical correlation of the Edmonton-33 instrument scores with swallowing, speech, dry mouth, and chewing assessment outcomes. RESULTS: In total, 10 patients with head and neck cancer (mean age, 59.6 years; 6 men [60%]) were included in phase 1 of the study, 5 patients (mean age, 55.2 years) were included in phase 2, 10 patients were included in phase 3, and 25 patients with head and neck cancer (mean age, 62.6 years; 14 men [56%]) participated in the phase 4 validation. The Edmonton-33 instrument scores correlated strongly with the swallowing scores of the MD Anderson Dysphagia Inventory (r = 0.77; 95% CI, 0.49-1.0), the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Head and Neck 35 (EORTC QLQ-H&N35) (r = -0.73; 95% CI, -1.0 to -0.44), and the modified barium swallow test (r = -0.60; 95% CI, -0.94 to -0.25). The instrument scores were also strongly correlated with the Speech Handicap Index scores (r = -0.64; 95% CI, -0.97 to -0.31), word intelligibility scores (r = 0.61; 95% CI, 0.27-0.95), and sentence intelligibility scores (r = 0.55; 95% CI, 0.19-0.91). A moderate to strong correlation was observed between the Edmonton-33 instrument and the EORTC QLQ-H&N35 scores in the dry mouth (r = -0.54; 95% CI, -0.91 to -0.18) and chewing (r = -0.45; 95% CI, -0.84 to -0.06) domains. The factor loading values for the domains of swallowing, speech, dry mouth, and chewing were all greater than 0.3. The mean factor loading values for the items related to swallowing were 0.71 (95% CI, 0.62-0.80) and for the items related to speech were 0.76 (95% CI, 0.72-0.80). The mean factor loading values for the items related to dry mouth were 0.71 (95% CI, 0.59-0.83) and for those related to chewing were 0.77 (95% CI, 0.69-0.85). CONCLUSIONS AND RELEVANCE: The Edmonton-33 appears to be a validated instrument that will allow patients with head and neck cancer to assess and report their own functional outcomes. It could serve as a single comprehensive measure for functional outcomes.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Mendez A, Seikaly H, Eurich D, et al. Development of a Patient-Centered Functional Outcomes Questionnaire in Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 32271362. doi:10.1001/jamaoto.2019.4788

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。